We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current DAWN market cap is 1.4B. The company's latest EPS is USD -2.1618 and P/E is -7.41.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -45.86M | -49.25M | -51.44M | -59.52M | -66.77M |
| Net Income | -42.39M | -45.86M | -46.15M | -54.51M | -62.41M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -14.91M | -13.78M | -72.74M | -146.91M | -206.06M |
| Net Income | -12.63M | -40.51M | -170.64M | -142.18M | -188.92M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 323.56M | 450.76M | 414.18M | 376.05M | 326.65M |
| Total Liabilities | 23.15M | 24.7M | 24.55M | 29.51M | 29.84M |
| Total Equity | 300.42M | 426.05M | 389.63M | 346.54M | 296.81M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 27.34M | 45.66M | 289.82M | 349.06M | 376.05M |
| Total Liabilities | 2.02M | 2.2M | 8.67M | 17.02M | 29.51M |
| Total Equity | -10.67M | -54.21M | 281.15M | 332.04M | 346.54M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -25.99M | -68.42M | -105.48M | -146.85M | -49.73M |
| Investing | -11.19M | 9.08M | 98M | 128.38M | 89.29M |
| Financing | 1.18M | 163.29M | 163.4M | 164M | 48k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.52M | -13.49M | -48.54M | -109.87M | -146.85M |
| Investing | N/A | -92k | -8M | -255.07M | 128.38M |
| Financing | 30.91M | 29.98M | 297.12M | 165.9M | 164M |
| Market Cap | 1.4B |
| Price to Earnings Ratio | -7.41 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.06 |
| Price to Book Ratio | 4.04 |
| Dividend Yield | - |
| Shares Outstanding | 87.39M |
| Average Volume (1 week) | 922.86k |
| Average Volume (1 Month) | 879.74k |
| 52 Week Change | 33.58% |
| 52 Week High | 18.0699 |
| 52 Week Low | 9.67 |
| Spread (Intraday) | 7.75 (36.05%) |
| Company Name | Day One Biopharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.dayonebio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
